Clinuvel Pharmaceuticals Limited
CLVLY · OTC
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Market Cap | $517,483 | $625,272 | $744,568 | $813,649 |
| - Cash | $224,106 | $16,821 | $183,868 | $38,817 |
| + Debt | $529 | $715 | $880 | $1,069 |
| Enterprise Value | $293,905 | $609,167 | $561,580 | $775,900 |
| Revenue | $59,372 | $35,648 | $55,376 | $32,257 |
| % Growth | 66.5% | -35.6% | 71.7% | – |
| Gross Profit | $40,604 | $32,589 | $50,086 | $16,920 |
| % Margin | 68.4% | 91.4% | 90.4% | 52.5% |
| EBITDA | $30,194 | $16,879 | $34,849 | $14,473 |
| % Margin | 50.9% | 47.4% | 62.9% | 44.9% |
| Net Income | $22,097 | $14,075 | $24,700 | $10,936 |
| % Margin | 37.2% | 39.5% | 44.6% | 33.9% |
| EPS Diluted | 0.44 | 0.28 | 0.49 | 0.21 |
| % Growth | 57.1% | -42.9% | 133.3% | – |
| Operating Cash Flow | $27,943 | $13,152 | $10,674 | $26,380 |
| Capital Expenditures | -$241 | -$58 | -$275 | -$5,302 |
| Free Cash Flow | $27,702 | $13,094 | $10,399 | $21,078 |